Freespira provides a medication-free treatment designed to reduce or stop panic attacks and PTSD symptoms by teaching breathing regulation.

Freespira

Domain Not Resolving

DNSSEC

Google Apps for Business

Squarespace Hosted

Google DNS

Google Cloud DNS

Google Domains

Founder

Beth Siegelman

President

Simon Thomas

Senior Vice President Strategic Accounts

Monica Frederick

Vice President, Strategic Accounts

Robert Hagan

Medical Director

Avrim Fishkind

Associate Member Marketing Director

Lynelle Hubbard

Sales and Support

Michael Ireland

Director of Client Success

Michelle Russell

Senior Director, Head of Marketing

Sarah Koenig

Quality

Shahan Hameed

Debra Reisenthel

Ned Scheetz

Russell Siegelman

Woodrow Myers

Chief Operating Officer & President

Joseph Perekupka

Chief Executive Officer

Camille McMullen

VP of Government Sales

Shawn Irwin

VP of Employer Sales & Strategy

Karin Bultman

SVP of Marketing

Eric Reeves

VP Strategic Accounts

Health Care Female Founded Companies with Late Stage Venture Funding

West Coast Late Stage Companies With Fewer Than 1000 Employees

Health Care Late Stage Companies With Less Than $10M in Revenue

Companies With Fewer Than 1000 Employees (Top 10K)

Freespira is at the forefront of revolutionizing behavioral healthcare with evidence based, at-home, drug-free solutions. Its flagship product, Freespira®, is the only FDA-cleared digital therapeutic proven to significantly reduce or eliminate panic attacks, panic disorder and PTSD symptoms in 28 days by training users to normalize respiratory irregularities.

Series E - Freespira, Inc.

Lightspeed Venture Partners

Series D - Freespira, Inc.

Series B - Freespira, Inc.

Venture Round - Freespira, Inc.

Debt Financing - Freespira, Inc.

Seed Round - Freespira, Inc.

Kirkland

Washington

United States

North America

Freespira, Inc.

PTSD Awareness Council Brings Together Providers, Patients, and Industry Leaders to Increase PTSD Awareness

Freespira and WellCare of Kentucky Bring Life-Changing Treatment to Panic Disorder and PTSD Sufferers

Freespira Appoints Joseph Perekupka as Chief Executive Officer to Fuel Continued Growth

Methods and systems for quantitative colorimetric capnometry

Freespira Welcomes Three New Executives to Fuel Continued Growth, Build on Proven Success, and Lead Expansion in Key Markets

Digital Therapeutics Trends And Considerations In Times Of Crises

A 28-day, at-home, medication-free treatment using a sensor and tablet to normalize breathing and reduce symptoms of panic attacks and PTSD.

Provides health plans with clinical evidence and real-world results of Freespira's effectiveness.

Offers information on how Freespira can reduce panic attacks and PTSD symptoms for employees, including clinical evidence and real-world results.

Information and guidance for individuals on how Freespira works, its benefits, and how to start treatment.

A dedicated program for veterans, providing the Freespira system to treat panic and PTSD symptoms, supported by clinical studies.

Enables healthcare providers to refer patients to the Freespira treatment, including information on insurance coverage.

Philippines

Asia

Vietnam

HTML5

Lightbox

Adobe Fonts

jQuery

Amazon EC2

GoDaddy Premium DNS

Gravity Forms

Google Tag Manager

Modernizr

F5 NGINX

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 13, 2024 8:59 AM	faac3945
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Sep 13, 2024 8:59 AM	5c8148e0
crunchbase trigger	general	Nov 18, 2024 2:12 PM	e341fd2a
crunchbase profile	general	Nov 18, 2024 3:49 PM	b8ee341d
li profile	general
translate crunchbase fundingrounds	general	Nov 18, 2024 4:18 PM	f7a3d15a
peers	general	Sep 13, 2024 8:59 AM	5c0b07e3
news basic	general	Sep 13, 2024 8:59 AM	96d111f0
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:FREESPIRA

Freespira